<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-151913</identifier>
<setSpec>0212-6567</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Prevalence of non-alcoholic fatty liver disease in a population with elevated transaminases and level of accuracy of the diagnosis in Primary Care</dc:title>
<dc:description xml:lang="en">Nonalcoholic fatty liver disease (NAFLD) is the most common cause of elevated transaminases in adults. Aim: Determine the prevalence of NASH in patients with sustained hypertransaminasemia, and Know the adequacy of the registered in Primary Care (AP) diagnosis. Material and methods: 1) Cross-sectional study with a random sample of patients with elevated alanine aminotransferase (ALT) held (ALT&gt; 32 for &amp;#8805;6 months), ruling out other causes of liver disease, according to clinical, laboratory and ultrasound scan criteria in AP and 2) cross-sectional description of all cases diagnosed with NASH recorded (K76 - ICD10) with diagnostic adequacy analysis according to standard criteria. Results: 290 patients were analyzed: 76 were diagnosed as NASH (26.1%), 44 women (57.9%). Multivariate analysis adjusted for age and sex showed no association between NASH and male gender (OR: 0.5; CI95%: 0.3-0.9), diabetes mellitus (DM) (OR: 2.42; CI95%: 1.2-4.9) and hypertension blood pressure (HBP) (OR: 3.07; CI 95% 1.6-5.6). Of the 209 diagnosed with NASH record: 51 (24.4%) met the criteria for NASH. The rest had insufficient records. Highlights: 53.1% lacked sustained hypertransaminasemia; 48% of viral serology; 11% supported and 53.1% abdominal ultrasound registration of alcohol. Conclusions: Severe NASH is frequent among patients with sustained hypertransaminasemia. The DM and hypertension significantly increase the risk of NASH. The diagnosis of NASH is recorded without considering all criteria and mainly NASH made by ultrasonography. They should unify diagnostic criteria in the register of NASH (AU)</dc:description>
<dc:creator>Samperio González, María Amelia</dc:creator>
<dc:creator>Méndez Gómez, Judit</dc:creator>
<dc:creator>Azagra, Rafael</dc:creator>
<dc:creator>Selvi Blasco, Marta</dc:creator>
<dc:creator>Manzano Montero, Mónica</dc:creator>
<dc:creator>Gil Prades, Montserrat</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La esteatosis hepática no alcohólica (EHNA) es la causa más frecuente de elevación de transaminasas en el adulto. Objetivos: Determinar la prevalencia de EHNA en pacientes con hipertransaminasemia mantenida, y conocer el grado de adecuación del diagnóstico registrado en Atención Primaria (AP). Material y métodos: 1) Estudio descriptivo transversal con muestra aleatoria de pacientes con elevación de la enzima alanina aminotransferasa (ALT) mantenida (ALT &gt; 32 durante &amp;#8805; 6 meses), descartadas otras causas de hepatopatía, siguiendo criterios clínicos, analíticos y ecográficos en AP, y 2) descriptivo transversal sobre todos los casos con diagnóstico de EHNA registrado (K76 - CIE10) con análisis de adecuación diagnóstica según criterios estándar. Resultados: Se analizaron 290 pacientes: 76 fueron diagnosticados de EHNA (26,1%), 44 mujeres (57,9%). El análisis multivariado ajustado por edad y sexo mostró asociación entre EHNA y sexo masculino (OR: 0,5; IC 95%: 0,3-0,9), diabetes mellitus (DM) (OR: 2,42; IC 95%: 1,2-4,9) e hipertensión arterial (HTA) (OR: 3,07; IC 95%: 1,6-5,6). De los 209 con registro diagnóstico de EHNA: 51 (24,4%) cumplían criterios de EHNA. El resto carecían de registros suficientes. Destacan: 53,1% carecían de hipertransaminasemia mantenida; 48% de serologías víricas; 11% de ecografía abdominal compatible y 53,1% de registro del consumo de alcohol. Conclusiones: La EHNA severa es frecuente entre los pacientes con hipertransaminasemia mantenida. La DM y la HTA incrementan significativamente el riesgo de EHNA. El diagnóstico de EHNA se registra sin considerar todos los criterios de EHNA y se hace mayoritariamente por ecografía. Se deberían unificar criterios diagnósticos en el registro de la EHNA (AU)</dc:description>
<dc:source>Aten Primaria;48(5): 281-287, mayo 2016. ^f281^l287</dc:source>
<dc:identifier>ibc-151913</dc:identifier>
<dc:title xml:lang="es">Prevalencia de la esteatosis hepática no alcohólica en población con hipertransaminasemia y grado de adecuación del diagnóstico registrado en atención primaria</dc:title>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d28418</dc:subject>
<dc:subject>^d55563^s22016</dc:subject>
<dc:subject>^d28571</dc:subject>
<dc:subject>^d24852</dc:subject>
<dc:subject>^d5337^s22053</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d28596</dc:subject>
<dc:subject>^d55563^s22053</dc:subject>
<dc:subject>^d11756^s22074</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d650</dc:subject>
<dc:subject>^d36032^s22053</dc:subject>
<dc:subject>^d8281^s22012</dc:subject>
<dc:subject>^d13411</dc:subject>
<dc:subject>^d8281^s22016</dc:subject>
<dc:subject>^d36032^s22012</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d22231^s22031</dc:subject>
<dc:subject>^d29315</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d55563^s29166</dc:subject>
<dc:subject>^d28584</dc:subject>
<dc:subject>^d9951^s22012</dc:subject>
<dc:subject>^d53386</dc:subject>
<dc:type>article</dc:type>
<dc:date>201605</dc:date>
</metadata>
</record>
</ibecs-document>
